A Leading Hedge Fund Just Placed Massive Bets on Broadcom and Intel Stocks. Should You Follow Suit?

Broadcom and Intel both project major revenue growth in 2027, with Broadcom’s custom AI ASIC business expected to generate $100B+ in 2027 as hyperscalers begin ramping chips designed with it. Despite Broadcom trading around 60x trailing earnings, the article argues a forward multiple of ~18x next year makes it a relative bargain, while Intel’s ~43x forward earnings looks expensive given continued foundry rebuilding. It also notes Coatue Management increased Broadcom stake by 6% in Q2 (to ~4.5% of the fund) and initiated a ~3.5% Intel position, implying the market may not fully price in the 2027 growth for Broadcom but may be ahead of itself for Intel.

Analysis

Broadcom looks like the cleaner way to express AI capex because the market is still valuing it like a mature supplier, not a platform that can monetize hyperscaler demand through multi-year custom silicon programs. The second-order effect is that ASIC adoption shifts dollars from generic compute into application-specific workloads, which can improve customer ROI while still leaving Broadcom with design-win lock-in, networking attach, and a longer revenue tail than the headline product cycle suggests. That matters most over 6-18 months: the re-rate is less about next quarter and more about whether 2027 tape-outs become visible enough to pull forward estimates.

Intel is a different story: the stock is increasingly a balance between operational progress and capital intensity, and the market may be underwriting too much margin recovery before foundry economics are proven. Revenue growth without a clear gross-margin inflection can become value-destructive if the company has to keep funding fabs and process improvements before utilization catches up. The key intermediate catalyst is not topline, but whether external foundry wins convert into sustained incremental margin over the next 2-3 earnings cycles.

Contrarian view: consensus may be overrating Intel’s turnaround optics and underrating how much Broadcom’s 2027 pipeline can compound before the market fully reflects it. The immediate trade is relative, not absolute: if hyperscaler commentary continues to emphasize cost-efficient inference and custom silicon, Broadcom should outperform even if both names look optically expensive. What would falsify that is any sign that ASIC programs slip, customer concentration rises without revenue conversion, or Intel’s foundry starts showing real operating leverage faster than expected.

Key Decisions for Investors

• Long AVGO / short INTC as a 3-6 month relative-value pair; thesis is that AVGO’s 2027 growth is under-discounted while INTC’s turnaround is already reflected. Falsify on a clear Intel margin inflection or if AVGO guidance implies design-win delays.
• Buy AVGO on any post-earnings pullback with a 12-18 month horizon, or express via call spreads if volatility cheapens; upside is a multiple re-rating as 2027 visibility improves, with risk limited to delayed tape-outs.
• Use INTC strength to initiate a tactical short or buy put spreads into earnings over the next 1-2 quarters; risk/reward favors downside if foundry revenue growth fails to translate into operating leverage.
• Watch NVDA as a secondary hedge: if hyperscaler commentary shifts toward custom ASICs, NVDA multiple support could weaken. No action until there is evidence of share shift, not just narrative.